Thoresen C E, Friedman M, Gill J K, Ulmer D K
Acta Med Scand Suppl. 1982;660:172-92. doi: 10.1111/j.0954-6820.1982.tb00373.x.
The Recurrent Coronary Prevention Project (RCPP) was established as a 5-year clinical trial to examine two basic questions: --1. Can the recurrence rate of post-coronary subjects be substantially reduced over a 5-year period by means of a programme of behavioural change, in comparison with treatment by cardiologists focussing on medication, diet, exercise and cardiovascular issues, and with subjects who only receive regular care from their own physician? 2. Can the Type A behaviour pattern (TABP) be changed and do such changes correspond to reduced recurrences of coronary heart disease (CHD) over a 5 year period? To answer these questions, four major treatment groups are currently being compared: --1. A small group treatment programme (Section I) led by cardiologists emphasizing adherence to medication, diet and exercise, and giving cardiovascular and cardiological information. 2. A behavioural change treatment programme (Section II) based primarily on a cognitive social learning model and attempting to alter TABP. 3. A control group of subjects assessed annually and receiving private medical care from their own physicians. 4. A dropout comparison group composed of subjects voluntarily discontinuing participation in groups led by cardiologists or in behavioural change groups. Results to date show a significantly reduced rate of recurrence for subjects in the behavioural change group, compared to those in the groups led by cardiologists as well as control and dropout groups. These significantly lower recurrence rates are accompanied by data suggesting that subjects in the behavioural change programme are also altering their TABP as measured by both behavioural questionnaires and videotaped Type A structured interviews. Clinical impressions suggest that treatment programmes to alter TABP should consider the primary importance of the personal meaning of the TABP and other behaviours to the individual concerned, particularly how basic underlying beliefs set the stage for the TABP. The central role of hostility as a pervasive orientation towards self and others is emphasized, as are issues of excessive controllability related to extreme competitiveness and hyper-arousal. The multiple roles of group leaders, especially as social models for coping, and the impact of the small groups settings, is also discussed.
复发性冠心病预防项目(RCPP)是一项为期5年的临床试验,旨在研究两个基本问题:1. 与专注于药物治疗、饮食、运动和心血管问题的心脏病专家治疗组以及仅接受自身医生常规护理的患者相比,通过行为改变计划,能否在5年内大幅降低冠心病患者的复发率?2. A型行为模式(TABP)能否改变,以及这种改变是否与5年内冠心病(CHD)复发率的降低相对应?为了回答这些问题,目前正在比较四个主要治疗组:1. 由心脏病专家领导的小组治疗计划(第一部分),强调坚持药物治疗、饮食和运动,并提供心血管和心脏病学信息。2. 主要基于认知社会学习模型并试图改变TABP的行为改变治疗计划(第二部分)。3. 每年接受评估并从自己的医生那里接受私人医疗护理的对照组。4. 由自愿停止参加心脏病专家领导的小组或行为改变小组的受试者组成的退出比较组。迄今为止的结果表明,与心脏病专家领导的小组以及对照组和退出组相比,行为改变组的受试者复发率显著降低。这些显著较低的复发率伴随着数据表明,行为改变计划中的受试者也在改变他们的TABP,这通过行为问卷和A型结构化访谈录像来衡量。临床印象表明,改变TABP的治疗计划应考虑TABP和其他行为对相关个体的个人意义的首要重要性,特别是基本的潜在信念如何为TABP奠定基础。强调了敌意作为对自我和他人的普遍取向的核心作用,以及与极端竞争和过度兴奋相关的过度可控性问题。还讨论了小组领导者的多重角色,特别是作为应对的社会榜样,以及小组环境的影响。